FDA reform needs to be underpinned by strategy, not ‘indiscriminate’ cuts The Trump administration could save the lives of ...

For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...

The licensing deal follows years of controversy for Cassava, as well as the high-profile late-stage failure of its ...

Eli Lilly (LLY) joins hands with Magnet Biomedicine in a deal worth up to $1.25B to develop cancer drugs using Magnet's ...

At the four new sites, Lilly expects to create more than 3,000 jobs for engineers, scientists, operations personnel, and lab technicians.

A group of Apple Watch buyers have filed a lawsuit in Silicon Valley accusing the tech giant of exaggerating how ...

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

The companies were two years into a four-year, $400 million agreement aimed at developing and marketing gene therapies ...

Eli Lilly will spend at least $27 billion dollars to build four manufacturing plants in the U.S. in order to move production back to America.

The breast cancer market has experienced robust growth, fueled by increased awareness and early detection efforts. Advances in diagnostic and treatme ...

Eli Lilly is doubling its U.S. manufacturing investment since 2020 as it seeks to produce more drugs domestically. Its latest ...

Eli Lilly is partnering with Imagine Entertainment and MACRO to drive industry-wide change and guide in authentically ...